153 related articles for article (PubMed ID: 29042321)
21. Pharmacokinetics of cefonicid in lactating goats after intravenous, intramuscular and subcutaneous administration, and after a long-acting formulation for subcutaneous administration.
Badillo E; Escudero E; Hernandis V; Galecio JS; Marín P
J Vet Pharmacol Ther; 2020 Jan; 43(1):50-56. PubMed ID: 31724779
[TBL] [Abstract][Full Text] [Related]
22. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
23. The contribution of the in-vivo fate of an oil depot to drug absorption.
Kalicharan RW; Oussoren C; Schot P; de Rijk E; Vromans H
Int J Pharm; 2017 Aug; 528(1-2):595-601. PubMed ID: 28629984
[TBL] [Abstract][Full Text] [Related]
24. Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxis.
Shaik JS; Weld ED; Edick S; Fuchs E; Riddler S; Marzinke MA; D'Amico R; Bakshi K; Lou Y; Hendrix C; Han K; Ford SL; Margolis D; Spreen W; Patel P
Br J Clin Pharmacol; 2022 Feb; 88(4):1667-1678. PubMed ID: 34240467
[TBL] [Abstract][Full Text] [Related]
25. Multimodal imaging distribution assessment of a liposomal antibiotic in an infectious disease model.
Cheng SH; Groseclose MR; Mininger C; Bergstrom M; Zhang L; Lenhard SC; Skedzielewski T; Kelley ZD; Comroe D; Hong H; Cui H; Hoover JL; Rittenhouse S; Castellino S; Jucker BM; Alsaid H
J Control Release; 2022 Dec; 352():199-210. PubMed ID: 36084816
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of a Sustained Release Formulation of Buprenorphine After Intramuscular and Subcutaneous Administration to American Kestrels ( Falco sparverius ).
Guzman DS; Knych HK; Olsen GH; Paul-Murphy JR
J Avian Med Surg; 2017 Jun; 31(2):102-107. PubMed ID: 28644085
[TBL] [Abstract][Full Text] [Related]
27. Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study.
Pavel M; Borson-Chazot F; Cailleux A; Hörsch D; Lahner H; Pivonello R; Tauchmanova L; Darstein C; Olsson H; Tiberg F; Ferone D
Cancer Chemother Pharmacol; 2019 Feb; 83(2):375-385. PubMed ID: 30535537
[TBL] [Abstract][Full Text] [Related]
28. Formulation and pharmacology of long-acting cabotegravir.
Trezza C; Ford SL; Spreen W; Pan R; Piscitelli S
Curr Opin HIV AIDS; 2015 Jul; 10(4):239-45. PubMed ID: 26049948
[TBL] [Abstract][Full Text] [Related]
29. Utility of quantitative whole-body autoradiography (QWBA) and imaging mass spectrometry (IMS) by matrix-assisted laser desorption/ionization (MALDI) in the assessment of ocular distribution of drugs.
Drexler DM; Tannehill-Gregg SH; Wang L; Brock BJ
J Pharmacol Toxicol Methods; 2011; 63(2):205-8. PubMed ID: 21040797
[TBL] [Abstract][Full Text] [Related]
30. Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
Brewer KD; Lake K; Pelot N; Stanford MM; DeBay DR; Penwell A; Weir GM; Karkada M; Mansour M; Bowen CV
Vaccine; 2014 Dec; 32(51):6956-6962. PubMed ID: 25444822
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
Swales JG; Tucker JW; Strittmatter N; Nilsson A; Cobice D; Clench MR; Mackay CL; Andren PE; Takáts Z; Webborn PJ; Goodwin RJ
Anal Chem; 2014 Aug; 86(16):8473-80. PubMed ID: 25084360
[TBL] [Abstract][Full Text] [Related]
32. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.
Drexler DM; Garrett TJ; Cantone JL; Diters RW; Mitroka JG; Prieto Conaway MC; Adams SP; Yost RA; Sanders M
J Pharmacol Toxicol Methods; 2007; 55(3):279-88. PubMed ID: 17222568
[TBL] [Abstract][Full Text] [Related]
33. Subcutaneous Administration of Insulin is Associated With Regional Differences in Injection Depot Variability and Kinetics in The Rat.
Gradel AKJ; Porsgaard T; Lykkesfeldt J; Brockhoff PB; Seested T; Refsgaard HHF
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):332-338. PubMed ID: 30075480
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.
Spreen W; Min S; Ford SL; Chen S; Lou Y; Bomar M; St Clair M; Piscitelli S; Fujiwara T
HIV Clin Trials; 2013; 14(5):192-203. PubMed ID: 24144896
[TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans.
Bowers GD; Culp A; Reese MJ; Tabolt G; Moss L; Piscitelli S; Huynh P; Wagner D; Ford SL; Gould EP; Pan R; Lou Y; Margolis DA; Spreen WR
Xenobiotica; 2016; 46(2):147-62. PubMed ID: 26134155
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor.
Cattaneo D; Gervasoni C
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):319-327. PubMed ID: 30387005
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
38. Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects.
Ford SL; Sutton K; Lou Y; Zhang Z; Tenorio A; Trezza C; Patel P; Spreen W
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739783
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of depot leuprorelin.
Periti P; Mazzei T; Mini E
Clin Pharmacokinet; 2002; 41(7):485-504. PubMed ID: 12083977
[TBL] [Abstract][Full Text] [Related]
40. The effect of route, vehicle, and divided doses on the pharmacokinetics of chlorpyrifos and its metabolite trichloropyridinol in neonatal Sprague-Dawley rats.
Marty MS; Domoradzki JY; Hansen SC; Timchalk C; Bartels MJ; Mattsson JL
Toxicol Sci; 2007 Dec; 100(2):360-73. PubMed ID: 17928393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
